Tradestie Institutional Equity Comparison Engine

AVDL vs LLY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Momentum & Technical, Options & Structure while LLY counters with relative strength in Growth & Margin. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus LLY at 26.5x Forward P/E and 51.2% operating margin (+38.6% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against LLY sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
AVDL 28.8x vs LLY 26.5x Fwd P/E
Growth & Margin Winner LLY
Op Margin 2.5% vs 51.2% ยท YoY +54.9% vs +38.6%
Momentum & Technical Winner AVDL
1Y +138.1% vs +28.4% ยท 52W Pos 89% vs 80%
Options & Structure Winner AVDL
UNCLASSIFIED (<1st %ile IV) vs CONSOLIDATION (23rd %ile IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
LLY NYSE
Eli Lilly & Co.
Pharmaceutical Preparations
$1,347.11
-0.3% 1D
Market Cap $1.20T
1M Return +3.09%
1Y Return +28.35%
Forward P/E 26.5x
Unified AI Score
41.4 / 100 SELL
Tech 39.0 Fund 44.0 Flow 67.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% LLY +28.35% Spread: +3.04 pp (LLY Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% LLY TTM Op. Margin: 51.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs LLY. Trailing 12-month operating profitability (AVDL 2.5% vs LLY 51.2%) and valuation multiples (AVDL 28.8x vs LLY 26.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (5) vs LLY (5)
Institutional Metric AVDL LLY Criterion Row Winner
Market Capitalization Scale $2.1B $1.20T Larger Scale LLY
Trailing P/E Ratio Valuation 16.8x 44.9x Lower Multiple AVDL
Forward P/E Ratio Valuation 28.8x 26.5x Lower Multiple LLY
Revenue Growth (YoY) Growth +54.9% +38.6% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 51.2% Higher Margin LLY
Net Profit Margin Profitability -0.1% 31.9% Higher Margin LLY
Return on Equity (ROE) Capital Efficiency -0.3% 86.0% Higher ROE LLY
52-Week Range Position Momentum 89% ($6โ€“$24) 80% ($851โ€“$1,475) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol 0.32ฮฒ ยท 36% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 41.4 / 100 (SELL) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs LLY Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LLY CONSOLIDATION
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live LLY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor LLY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.